Literature DB >> 30229300

Reduced CD8+ T cells infiltration can be associated to a malignant transformation in potentially malignant oral epithelial lesions.

Aline Lauda Freitas Chaves1,2, Ana Gabriela Silva1,2, Flávia Medeiros Maia1,2, Gabriela Francine Martins Lopes2, Luiz Fernando Barbosa de Paulo1,3, Luciana Vieira Muniz1,4, Hélio Batista Dos Santos1,2, João Marcos Arantes Soares1,2, Alexandre Andrade Souza1,2, Leandro Augusto de Oliveira Barbosa1,2, Adriano Mota Loyola1,3, Eddie Fernando Candido Murta1,5, Márcia Antoniaze Michelin1,5, Rosy Iara Maciel de Azambuja Ribeiro6,7.   

Abstract

OBJECTIVE: The aim of this study was to evaluate the immunohistochemical expressions of PD1, CD4+, and CD8+ in premalignant lesions (OPML) that were transformed into oral squamous cell carcinoma OSCC (OPML-OSCC), in OSCC and also in premalignant lesions that were not transformed into OSCC (OPML-NOSSC).
MATERIALS AND METHODS: Retrospective analyses were performed in order to verify the demographic characteristics of the patients. CD4, CD8, and PD1 IMH studies were carried out on OPML and OSCC samples from 11 patients with OPML-OSCC and OPML, together with samples from 14 patients with OPML-NOSCC. The differences between OPML-OSCC and OPML-NOSCC were analyzed.
RESULTS: Non-homogenous leukoplakia, together with the related oral subsite, and the lack of an exposure to tobacco, were all associated with malignant transformations. There were no statistical differences in the PD1 expression and the CD4+ cells in OPML-OSCC and OPML-NOSCC. A significant increment in the CD8+ cells was noted in the OPML that evolved into carcinomas when compared with OPML-NOSCC (p = 0.05), whereas there were higher CD8+ cells levels in the carcinomas when compared with the OPML that evolved into carcinomas (p = 0.027).
CONCLUSIONS: CD8+ cells infiltrate more in OPML-NOSCC than in OPML-OSCC. Carcinoma is more infiltrated by CD8+ cells than its associated OPML. CLINICAL RELEVANCE: Understanding immunological factors associated with malignant transformation of oral premalignant lesions can open a new way to treat this disease.

Entities:  

Keywords:  Cancerization; Early diagnosis; Malignant transformation; Oral cancer

Year:  2018        PMID: 30229300     DOI: 10.1007/s00784-018-2622-8

Source DB:  PubMed          Journal:  Clin Oral Investig        ISSN: 1432-6981            Impact factor:   3.573


  12 in total

Review 1.  Cancer Immunoprevention: Current Status and Future Directions.

Authors:  Mahsa Keshavarz-Fathi; Nima Rezaei
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2021-02-27       Impact factor: 4.291

2.  Clinical and Histological Prognostic Factors of Recurrence and Malignant Transformation in a Large Series of Oral Potentially Malignant Disorders.

Authors:  Luigi Lorini; Michele Tomasoni; Cristina Gurizzan; Chiara Magri; Mattia Facchetti; Simonetta Battocchio; Chiara Romani; Marco Ravanelli; Arianna Oberti; Anna Bozzola; Elena Bardellini; Alberto Paderno; Davide Mattavelli; Davide Lombardi; Alberto Grammatica; Alberto Deganello; Fabio Facchetti; Stefano Calza; Alessandra Majorana; Cesare Piazza; Paolo Bossi
Journal:  Front Oncol       Date:  2022-04-21       Impact factor: 5.738

3.  Immunotherapy for the prevention of high-risk oral disorders malignant transformation: the IMPEDE trial.

Authors:  Cristina Gurizzan; Luigi Lorini; Alberto Paderno; Michele Tomasoni; Gabriele Zigliani; Anna Bozzola; Laura Ardighieri; Simonetta Battocchio; Eliana Bignotti; Antonella Ravaggi; Chiara Romani; Loris De Cecco; Mara Serena Serafini; Rosalba Miceli; Elena Bardellini; Alessandra Majorana; Cesare Piazza; Paolo Bossi
Journal:  BMC Cancer       Date:  2021-05-17       Impact factor: 4.430

4.  Early changes in the immune microenvironment of oral potentially malignant disorders reveal an unexpected association of M2 macrophages with oral cancer free survival.

Authors:  Jebrane Bouaoud; Jean-Philippe Foy; Antonin Tortereau; Lucas Michon; Vincent Lavergne; Nicolas Gadot; Sandrine Boyault; Julie Valantin; Geneviève De Souza; Philippe Zrounba; Chloé Bertolus; Nathalie Bendriss-Vermare; Pierre Saintigny
Journal:  Oncoimmunology       Date:  2021-06-27       Impact factor: 8.110

5.  Association between p62 expression and clinicopathological characteristics in oral leukoplakia.

Authors:  Toshio Yoshida; Takehito Terabe; Hiroki Nagai; Fumihiko Uchida; Shogo Hasegawa; Toru Nagao; Satoru Miyabe; Naomi Ishibashi-Kanno; Kenji Yamagata; Eiji Warabi; Masahiko Gosho; Toru Yanagawa; Hiroki Bukawa
Journal:  Clin Exp Dent Res       Date:  2019-06-25

6.  Malignant transformation of oral potentially malignant disorders in Taiwan: An observational nationwide population database study.

Authors:  Sheng-Fu Chiu; Chung-Han Ho; Yi-Chen Chen; Li-Wha Wu; Yuh-Ling Chen; Jer-Horng Wu; Wei-Sheng Wu; Hui-Kun Hung; Wei-Fan Chiang
Journal:  Medicine (Baltimore)       Date:  2021-03-05       Impact factor: 1.817

Review 7.  Unmet Needs and Perspectives in Oral Cancer Prevention.

Authors:  Jebrane Bouaoud; Paolo Bossi; Moshe Elkabets; Sandra Schmitz; Léon C van Kempen; Pierre Martinez; Sankar Jagadeeshan; Ingrid Breuskin; Gerwin J Puppels; Caroline Hoffmann; Keith D Hunter; Christian Simon; Jean-Pascal Machiels; Vincent Grégoire; Chloé Bertolus; Ruud H Brakenhoff; Senada Koljenović; Pierre Saintigny
Journal:  Cancers (Basel)       Date:  2022-04-02       Impact factor: 6.639

8.  Dynamic changes of exhaustion features in T cells during oral carcinogenesis.

Authors:  Wenqiang Xie; Jie Shen; Dikan Wang; Junyi Guo; Qunxing Li; Shuqiong Wen; Wenxiao Dai; Liling Wen; Huanzi Lu; Juan Fang; Zhi Wang
Journal:  Cell Prolif       Date:  2022-02-18       Impact factor: 8.755

9.  The Effectiveness of Laser-Assisted Surgical Excision of Leukoplakias and Hyperkeratosis of Oral Mucosa: A Case Series in A Group of Patients.

Authors:  Dorina Lauritano; Alberta Lucchese; Federica Gabrione; Dario Di Stasio; Javier Silvestre Rangil; Francesco Carinci
Journal:  Int J Environ Res Public Health       Date:  2019-01-13       Impact factor: 3.390

Review 10.  Leukoplakia and Immunology: New Chemoprevention Landscapes?

Authors:  Roberto Grigolato; Maria Eleonora Bizzoca; Luca Calabrese; Stefania Leuci; Michele Davide Mignogna; Lorenzo Lo Muzio
Journal:  Int J Mol Sci       Date:  2020-09-19       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.